Low gene expression of bone morphogenetic protein 7 in brainstem astrocytes in major depression

International Journal of Neuropsychopharmacology

Volumn 15, Issue 7, 2012, Pages 855-868

  Ordway, Gregory A ^a   Szebeni, Attila ^a   Chandley, Michelle J ^a   Stockmeier, Craig A ^b   Xiang, Lianbin ^b   Newton, Samuel S ^c   Turecki, Gustavo ^d   Duffourc, Michelle M ^a   Zhu, Meng Yang ^a   Zhu, Hobart ^a   Szebeni, Katalin ^a  

^a East Tennessee State University   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Astrocyte; bone morphogenetic protein; glia; locud coeruleus; major depression; noradrenergic; suicide

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN; OSTEOGENIC PROTEIN 1;

AMYGDALOID NUCLEUS; ARTICLE; ASTROCYTE; BRAIN HOMOGENATE; BRAIN STEM; CATECHOLAMINE NERVE CELL; CELL MATURATION; CHRONIC STRESS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LASER CAPTURE MICRODISSECTION; LOCUS CERULEUS; MAJOR DEPRESSION; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NORADRENERGIC NERVE; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PHOBIA; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; BONE MORPHOGENETIC PROTEIN 7; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BRAIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LOCUS COERULEUS; MALE; MICRODISSECTION; MIDDLE AGED; RATS; RETROSPECTIVE STUDIES; TYROSINE 3-MONOOXYGENASE; YOUNG ADULT;

EID: 84864335063     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001350     Document Type: Article

References (63)

1. Allen Brain Atlas Resource (2009). (http://www. brain-map.org). Seattle, WA: Allen Institute for Brain Science.
2. Attisano L, Wrana JL (2002). Signal transduction by the TGF-beta superfamily. Science 296, 1646-1647.
3. Banasr M, Duman RS (2007). Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS and Neurological Disorders-Drug Targets 6, 311-320. (Pubitemid 351492092)
4. Bekar LK, He W, Nedergaard M (2008). Locus coeruleus alpha-adrenergic- mediated activation of cortical astrocytes in vivo. Cerebral Cortex 18, 2789-2795.
5. Berman RM, Narasimhan M, Miller HL, Anand A, et al. (1999). Transient depressive relapse induced by catecholamine depletion : potential phenotypic vulnerability marker? Archives of General Psychiatry 56, 395-403. (Pubitemid 29215426)
6. Bernard R, Kerman IA, Thompson RC, Jones EG, et al. (2011). Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Molecular Psychiatry 16, 634-646.
7. Bowley MP, Drevets WC, Ongur D, Price JL (2002). Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry 52, 404-412. (Pubitemid 35266731)
8. Brederlau A, Faigle R, Kaplan P, Odin P, et al. (2002). Bone morphogenetic proteins but not growth differentiation factors induce dopaminergic differentiation in mesencephalic precursors. Molecular and Cellular Neuroscience 21, 367-378. (Pubitemid 36062725)
9. Canalis E, Economides AN, Gazzerro E (2003). Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine Reviews 24, 218-235. (Pubitemid 36515285)
10. Chang CF, Lin SZ, Chiang YH, Morales M, et al. (2003). Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34, 558-564. (Pubitemid 36206364)
11. Charney DS (1998). Monoamine dysfunction and the pathophysiology and treatment of depression. Journal of Clinical Psychiatry 59 (Suppl. 14), 11-14. (Pubitemid 28462383)
12. Charytoniuk DA, Traiffort E, Pinard E, Issertial O, et al. (2000). Distribution of bone morphogenetic protein and bone morphogenetic protein receptor transcripts in the rodent nervous system and up-regulation of bone morphogenetic protein receptor type II in hippocampal dentate gyrus in a rat model of global cerebral ischemia. Neuroscience 100, 33-43. (Pubitemid 30670299)
13. Chen HL, Lein PJ, Wang JY, Gash D, et al. (2003). Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Research 994, 81-90. (Pubitemid 37452440)
14. Cotter D, Mackay D, Landau S, Kerwin R, et al. (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry 58, 545-553. (Pubitemid 32523734)
15. Dow AL, Russell DS, Duman RS (2005). Regulation of activin mRNA and smad2 phosphorylation by antidepressant treatment in the rat brain : effects in behavioral models. Journal of Neuroscience 25, 4908-4916. (Pubitemid 40712834)
16. Dumais A, Lesage AD, Alda M, Rouleau G, et al. (2005). Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. American Journal of Psychiatry 162, 2116-2124. (Pubitemid 41598266)
17. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127.
18. Fatemi SH, Laurence JA, Araghi-Niknam M, Stary JM, et al. (2004). Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophrenia Research 69, 317-323. (Pubitemid 38721429)
19. Fleige S, Pfaffl MW (2006). RNA integrity and the effect on the real-time qRT-PCR performance. Molecular Aspects of Medicine 27, 126-139.
20. Garriock HA, Kraft JB, Shyn SI, Peters EJ, et al. (2010). A genomewide association study of citalopram response in major depressive disorder. Biological Psychiatry 67, 133-138.
21. Gos T, Krell D, Bielau H, Brisch R, et al. (2008). Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. European Archives of Psychiatry and Clinical Neuroscience 258, 513-520.
22. Gross RE, Mehler MF, Mabie PC, Zang Z, et al. (1996). Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17, 595-606. (Pubitemid 26365340)
23. Guo X, Rueger D, Higgins D (1998). Osteogenic protein-1 and related bone morphogenetic proteins regulate dendritic growth and the expression of microtubule-associated protein-2 in rat sympathetic neurons. Neuroscience Letters 245, 131-134. (Pubitemid 28287340)
24. Harvey BK, Hoffer BJ, Wang Y (2005). Stroke and TGF-beta proteins : glial cell line-derived neurotrophic factor and bone morphogenetic protein. Pharmacology and Therapeutics 105, 113-125.
25. Harvey BK, Mark A, Chou J, Chen GJ, et al. (2004). Neurotrophic effects of bone morphogenetic protein-7 in a rat model of parkinson's disease. Brain Research 1022, 88-95. (Pubitemid 39194988)
26. Hertz L, Chen Y, Gibbs ME, Zang P, et al. (2004). Astrocytic adrenoceptors : a major drug target in neurological and psychiatric disorders? CNS and Neurological Disorders-Drug Targets 3, 239-267. (Pubitemid 38854918)
27. Jordan J, Bottner M, Schluesener HJ, Unsicker K, et al. (1997). Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. European Journal of Neuroscience 9, 1699-1709. (Pubitemid 27348328)
28. Karolewicz B, Stockmeier CA, Ordway GA (2005). Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression. Neuropsychopharmacology 30, 1557-1567. (Pubitemid 41153128)
29. Kawamata T, Ren J, Chan TC, Charette M, et al. (1998). Intracisternal osteogenic protein-1 enhances functional recovery following focal stroke. Neuroreport 9, 1441-1445. (Pubitemid 28264266)
30. Kessler RC, Berglund P, Demler O, Jin R, et al. (2003). The epidemiology of major depressive disorder : results from the national comorbidity survey replication (NCS-R). Journal of the American Medical Association 289, 3095-3105. (Pubitemid 37432885)
31. Koolhaas JM, De Boer SF, De Rutter AJ, Meerlo P, et al. (1997). Social stress in rats and mice. Acta Physiologica Scandanavica Supplement 640, 69-72. (Pubitemid 27496284)
32. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature 455, 894-902.
33. Lein P, Guo X, Hedges AM, Rueger D, et al. (1996). The effects of extracellular matrix and osteogenic protein-1 on the morphological differentiation of rat sympathetic neurons. International Journal of Developmental Neuroscience 14, 203-215. (Pubitemid 26238166)
34. Lein P, Johnson M, Guo X, Rueger D, et al. (2002a) Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons. Neuron 15, 597-605.
35. Lein PJ, Beck HN, Chandrasekaran V, Gallagher PJ, et al. (2002b). Glia induce dendritic growth in cultured sympathetic neurons by modulating the balance between bone morphogenetic proteins (BMPs) and BMP antagonists. Journal of Neuroscience 22, 10377-10387. (Pubitemid 35416875)
36. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta c(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
37. Mabie PC, Mehler MF, Marmur R, Papavasiliou A, et al. (1997). Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial- astroglial progenitor cells. Journal of Neuroscience 17, 4112-4120. (Pubitemid 27220602)
38. Miczek KA (1991). Tolerance to the analgesic, but not discriminative stimulus effects of morphine after brief social defeat in rats. Psychopharmacology (Berlin) 104, 181-186.
39. Montgomery SA, Baldwin DS, Blier P, Fineberg NA, et al. (2007). Which antidepressants have demonstrated superior efficacy? a review of the evidence. International Clinical Psychopharmacology 22, 323-329. (Pubitemid 47530836)
40. Ongur D, Drevets WC, Price JL (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290-13295. (Pubitemid 28509564)
41. Ordway GA (2007). Neuropathology of central norepinephrine in psychiatric disorders : postmortem research. In : Ordway GA, Schwartz MA, Frazer A (Eds), Brain Norepinephrine : Neurobiology and Therapeutics (pp. 341-362). Cambridge, UK: Cambridge University Press.
42. Ordway GA, Klimek V, Mann JJ, Davis KL, et al. (2002). Neurocircuitry of mood disorders. In : Davis KL, Charney D, Coyle JT, Nemeroff C (Eds), Neuropsychopharmacology: The Fifth Generation of Progress (pp. 1051-1064). Philadelphia: Lippincott Williams & Wilkins.
43. Ordway GA, Stockmeier CA, Cason GW, Klimek V (1997). Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. Journal of Neuroscience 17, 1710-1719. (Pubitemid 27089816)
44. Ordway GA, Szebeni A, Duffourc MM, Dessus-Babus S, et al. (2009). Gene expression analyses of neurons, astrocytes, and oligodendrocytes isolated by laser capture microdissection from human brain : detrimental effects of laboratory humidity. Journal of Neuroscience Research 87, 2430-2438.
45. Papakostas GI, Thase ME, Fava M, Nelson JC, et al. (2007). Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? a meta-analysis of studies of newer agents. Biological Psychiatry 62, 1217-1227. (Pubitemid 350060895)
46. Paykel ES, Myers JK, Dienelt MN, Klerman GL, et al. (1969). Life events and depression. a controlled study. Archives of General Psychiatry 21, 753-760.
47. Perides G, Jensen FE, Edgecomb P, Rueger DC, et al. (1995). Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia. Neuroscience Letters 187, 21-24.
48. Porter JT, McCarthy KD (1997). Astrocytic neurotransmitter receptors in situ and in vivo. Progress in Neurobiology 51, 439-455. (Pubitemid 27170170)
49. Pudovkina OL, Kawahara Y, de Vries J, Westerink BH (2001). The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Research 906, 38-45. (Pubitemid 32595537)
50. Rajkowska G, Miguel-Hidalgo JJ (2007). Gliogenesis and glial pathology in depression. CNS & Neurological Disorders-Drug Targets 6, 219-233. (Pubitemid 46916253)
51. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry 45, 1085-1098. (Pubitemid 29236550)
52. Rygula R, Abumaria N, Flugge G, Fuchs E, et al. (2005). Anhedonia and motivational deficits in rats : impact of chronic social stress. Behavioral Brain Research 162, 127-134. (Pubitemid 40731540)
53. Salomon RM, Miller HL, Krystal JH, Heninger GR, et al. (1997). Lack of behavioral effects of monoamine depletion in healthy subjects. Biological Psychiatry 41, 58-64. (Pubitemid 27050646)
54. Schneider C, Wicht H, Enderich J, Wegner M, et al. (1999). Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 24, 861-870. (Pubitemid 30017665)
55. Schroeder A, Mueller O, Stocker S, Salowsky R, et al. (2006). The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Molecular Biology 7, 3.
56. Shibata E, Sasaki M, Tohyama K, Otsuka K, et al. (2007). Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging. Neuroreport 18, 415-418. (Pubitemid 46668026)
57. Shibata E, Sasaki M, Tohyama K, Otsuka K, et al. (2008). Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biological Psychiatry 64, 401-406.
58. Stockmeier CA, Shi X, Konick L, Overholser JC, et al. (2002). Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport 13, 1223-1227. (Pubitemid 34722058)
59. Thase ME (2009). Update on partial response in depression. Journal of Clinical Psychiatry 70 (Suppl. 6), 4-9.
60. Tilleman H, Hakim V, Novikov O, Liser K, et al. (2010). Bmp5/7 in concert with the mid-hindbrain organizer control development of noradrenergic locus coeruleus neurons. Molecular and Cellular Neuroscience 45, 1-11.
61. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders : a study from the stanley neuropathology consortium. Schizophrenia Research 67, 269-275. (Pubitemid 38251458)
62. Vandesompele J, De Preter K, Pattyn F, Poppe B, et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3, research0034.1-0034.11.
63. Xiang L, Szebeni K, Szebeni A, Klimek V, et al. (2008). Dopamine receptor gene expression in human amygdaloid nuclei : elevated d4 receptor mRNA in major depression. Brain Research 1207, 214-224.